Mumbai, India

Krishna K Maheshwari

This inventor holds 1 USPTO granted patent. Top assignee: Usv Private Limited. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Krishna K Maheshwari. Retrieved from https://idiyas.com/inventor/krishna-k-maheshwari

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Krishna K Maheshwari: Innovator in Pharmaceutical Chemistry

Introduction

Krishna K Maheshwari is a notable inventor based in Mumbai, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the area of racemization processes. His work has implications for the development of various pharmaceutical compounds.

Latest Patents

Krishna holds a patent for the "Racemization of optically active 2-substituted phenyl glycine esters." This innovation showcases his expertise in creating methods that enhance the efficiency of chemical processes in drug development. He has 1 patent to his name, reflecting his commitment to advancing scientific knowledge.

Career Highlights

Krishna is currently employed at USV Private Limited, a prominent pharmaceutical company in India. His role involves research and development, where he applies his innovative ideas to real-world challenges in the pharmaceutical industry. His work contributes to the company's mission of improving healthcare through advanced drug formulations.

Collaborations

Throughout his career, Krishna has collaborated with talented individuals such as Anup Ramkrishna Barde and Shreerang Vidyadhar Joshi. These collaborations have fostered a creative environment that encourages the exchange of ideas and enhances the quality of their research.

Conclusion

Krishna K Maheshwari is a dedicated inventor whose work in pharmaceutical chemistry is paving the way for new advancements in drug development. His contributions are vital to the ongoing evolution of the industry, and his innovative spirit continues to inspire those around him.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…